Along with breast cancer, cervical cancer is among the most feared cancer diagnoses for women around the world.

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...

In 2021, the FDA blasted Merck for using a premature endpoint to pursue a Keytruda approval in early-stage triple-negative breast cancer (TNBC). Now, the PD-1 inhibitor has gold-standard overall ...

This marks Keytruda's first approval for the given indication. Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

LANSDALE — Fall 2024 could bring a new round of talks on a frequent topic in Lansdale: police hiring. Council members heard an update on the borough police department’s staffing levels, and a ...

Monday, September 23, at 7 p.m. — 'A Look Back at the Lansdale Centennial of 1972.' The program, filled with photos and narrated by Linda Evans, will show how Lansdale celebrated its 100 years ...

After hours: September 20 at 7:52 PM EDT Loading Chart for MRK ...

Rumours that Merck was planning a $30 billion-plus takeover bid for Seagen have so far come to nothing, but it did complete a deal to buy VelosBio for $2.75 billion in late 2020 to add an ADC ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Analysts see big upside for these undervalued health care stocks.